Kızıl ile İlişkili Nadir Bir Komplikasyon: Akut Hepatit

Öz

Çocuklarda akut tonsillofarenjitin en yaygın bakteriyel etkeni A grubu beta hemolitik streptokoktur. Eritrojenik ekzotoksinler üreten A grubu beta hemolitik streptokok suşları kızıl olarak bilinen tipik bir döküntülü hastalık oluşturur. Komplikasyonları iyi tanımlanmıştır. Hepatit nadir bir komplikasyonudur. Burada, 7 yaşında kızıl olan ve karaciğer enzimleri yükselmiş bir kız hasta sunulmuştur. Hepatite yol açan virüsler gösterilememiştir. Boğaz kültüründe A grubu beta hemolitik streptokok üremiştir. A grubu beta hemolitik streptokok enfeksiyonlarında hepatit gelişebileceği göz ardı edilmemelidir.

Anahtar Kelimeler

• Hepatit, Kızıl, Streptokok

A Rare Complication Associated with Scarlet Fever: Acute Hepatitis

Öz

The most common cause of tonsillopharyngitis is group A beta hemolytic streptococcal infection in children. Group A beta hemolytic streptococcus strains that produce erythrogenic exotoxins cause a typical exanthematous disease called scarlet fever. Complications are well described. Hepatitis is a rare complication. We present a 7-year old girl with scarlet fever and elevated liver transaminases in this report. Viruses that lead to hepatitis were not demonstrated. Group A beta hemolytic streptococcus was isolated from the throat culture of the patient. Hepatitis should not be overlooked in patients with group A beta hemolytic streptococcal infections

Anahtar Kelimeler

• Hepatitis, Scarlet fever, Streptococcus

Kaynakça

1. Steer AC, Danchin MH, Carapetis JR. Group A streptococcal infections in children. J Paediatr Child Health 2007;43:203-13.
2. Wong SSY, Yuen KY. Streptococcus pyogenes and re-emergence of scarlet fever as a public health problem. Emerging Microbes & Infections 2012;1:e2;doi:10.1038/emi.2012.9 Published online 11 July 2012
3. Gutiérrez Junquera C, Escudero Canto MC, Ruiz Cano R, Cuartero del Pozo I, Gil Pons E. Cholestatic hepatitis as initial manifestation of scarlet fever. An Pediatr (Barc) 2003;59:193–4.
4. Gómez-Carrasco JA, Lassaletta A, Ruano D. Acute hepatitis may form part of scarlet fever. An Pediatr (Barc) 2004;60:382–3.
5. Gidaris D, Zafeiriou D, Mavridis P, Gombakis N. Scarlet fever and hepatitis: A case report. Hippokratia 2008;12:186–7.
6. Girisch M, Heininger U. Scarlet fever associated with hepatitis-A report of two cases. Infection 2000; 28:251–3.
7. Elishkewitz K, Shapiro R, Amir J, Nussinovitch M. Hepatitis in scarlet fever. Isr Med Assoc J 2004;6:569-70.
8. Norrby-Teglund A, Chatellier S, Low DE, McGeer A, Green K, Kotb M. Host variations in cytokine responses to superantigens determine the severity of invasive group A streptococcal infection. Eur J Immunol 2000;30:3247-55.

9. Brody H, Smith LW. The visceral pathology in scarlet fever and the related Streptococcus infections. Amer J Path 1936;12:373- 394.5.
10. Stevens DL. Streptococcal toxic-shock syndrome: Spectrum of disease, pathogenesis, and new concepts in treatment. Emerg Infect Dis 1995;1:69-78.
11. Mcmahon HE, Mallry FB. Streptococcus hepatitis. Am J Pathol 1931;7:299-325.
12. Kocak N, Ozsoylu S, Ertugrul M, Ozdol G. Liver damage in scarlet fever. Descriptions of two affected children. Clin Pediatr (Phila) 1976;15:462-4.
13. Robbens E, De Man M, Schurgers M, Boelaert J, Lameire N. Systemic complications of streptococcal scarlet fever: Two case reports and a review of the literature. Acta Clin Belg 1986;41: 311-8.
14. Jansen TL, Janssen M, de Jong AJ, Jeurissen ME. Post strep- tococcal reactive arthritis: A clinical and serological description, revealing its distinction from acute rheumatic fever. J Intern Med 1999;245:261-7.
15. Demers B, Simor AE, Vellend H, Schlievert PM, Byrne S, Jamieson F, et al. Severe invasive group A streptococcal infections in Ontario, Canada: 1987-1991. Clin Infect Dis 1993;16:792-800.